Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non
about
Biomarkers for detection of alcohol consumption in liver transplantationDiagnosis and Management of Alcoholic Liver DiseaseRecommendations for the Design and Analysis of Treatment Trials for Alcohol Use DisordersProteomic approaches and identification of novel therapeutic targets for alcoholismDiagnosis of alcoholic liver disease.Diagnostic challenges in alcohol use disorder and alcoholic liver diseaseCirculating cytokines as biomarkers of alcohol abuse and alcoholismClinical differences between alcoholic liver disease and nonalcoholic fatty liver disease.Novel Objective Biomarkers of Alcohol Use: Potential Diagnostic and Treatment Management Tools in Dual Diagnosis CareFuture prospects for biomarkers of alcohol consumption and alcohol-induced disordersPlasma proteomic alterations in non-human primates and humans after chronic alcohol self-administration.Determination of carbohydrate-deficient transferrin in a Han Chinese population.Impact of a clinical pathway on treatment outcome in patients with acute pancreatitis.Sensitivity and specificity of urinary ethyl glucuronide and ethyl sulfate in liver disease patients.Molecular targets of alcohol action: Translational research for pharmacotherapy development and screening.Trends in the management and burden of alcoholic liver disease.Pathophysiology and Management of Alcoholic Liver Disease: Update 2016.Alcohol withdrawal syndrome: mechanisms, manifestations, and management.Good outcome after liver transplantation for ALD without a 6 months abstinence rule prior to transplantation including post-transplant CDT monitoring for alcohol relapse assessment - a retrospective study.How has screening of harmful drinking changed over the years?Multivariate strategies for screening evaluation of harmful drinking.Applications and Challenges for the Use of Phosphatidylethanol Testing in Liver Disease Patients (Mini Review).Biomarkers demonstrate increased consumption, but not abuse, of ethanol in essential tremor.Profiles of biomarkers of excess alcohol consumption in patients undergoing total hip replacement: correlation with function.Alcoholic liver disease.Alcohol Biomarkers in Clinical and Forensic Contexts.
P2860
Q26748593-D78FF47B-D259-4174-A82E-869EA6B87381Q26781876-725DD477-AD4D-4F82-912A-00D32EFB4A54Q27013929-0223C418-8707-4EE1-952C-A06D9F1A5073Q27023085-A0546314-8D20-4A43-996A-4D2860011637Q30431186-8BF4FB38-5C9D-4051-8B91-0FC0DDC33CAEQ30435189-6A7B9B2A-772D-4257-86B8-C87B764C5193Q33821192-6864C52C-7A0D-45CB-B8F6-7D2211A0EAB3Q33886948-4B0A6CC9-95CF-42AA-8866-6F970E3758F0Q33938589-7D8767CA-3784-4BDE-80F3-9FF2E1DE4804Q33976216-206FC468-36E9-42D7-A1C2-4146D75C8A7DQ35024002-DA880011-1825-4268-8EFC-CBBD7A1A8122Q35103219-497FFA2E-2E5C-45C1-9CFA-DF83AE30C654Q35942435-5624DA2E-52E7-450A-837C-56F51D67E451Q36282353-61FF4BF0-25C9-40BC-AB4C-C5052FEA0B0CQ36581622-A876743C-5B08-4D00-BDAC-30FEC2B1AA28Q37237035-E13E42DE-8126-4D7C-BD47-0555708AEF82Q37696026-4770DF3A-8DD5-442C-B650-BEEEE4FB43C2Q38944364-84715A9B-BA55-4E3C-BA9E-5534881530C1Q40006213-D05A531B-9C0C-4603-B5D9-0BB3CA072F3FQ45354282-7C8E24D0-F9B5-4035-B070-ED6E516716C3Q46581530-C3C350E2-1A1E-4920-BF80-7DAAAD1A9C52Q48272231-729C9675-01E1-45BC-85FD-7E1085638CE2Q50261705-2B256BAB-5D5E-4E89-8AC6-15FEBBDEEA56Q51656283-04C3FA88-F35A-4486-9BB3-801BF63744C1Q51764048-CC42B94E-C3BE-4696-BF4D-52C2886E1397Q55098054-B09C3EFF-648E-40EC-AB45-E932354E36E8
P2860
Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Validity of carbohydrate-defic ...... nce and liver disorders of non
@en
Validity of carbohydrate-defic ...... nce and liver disorders of non
@nl
type
label
Validity of carbohydrate-defic ...... nce and liver disorders of non
@en
Validity of carbohydrate-defic ...... nce and liver disorders of non
@nl
prefLabel
Validity of carbohydrate-defic ...... nce and liver disorders of non
@en
Validity of carbohydrate-defic ...... nce and liver disorders of non
@nl
P2093
P2860
P1433
P1476
Validity of carbohydrate-defic ...... nce and liver disorders of non
@en
P2093
Grunert VP
Schiemann U
Wuertemberger M
P2860
P304
P356
10.1111/J.1360-0443.2005.01216.X
P407
P577
2005-10-01T00:00:00Z